About Acorn Biolabs
Acorn Biolabs is a company based in Toronto (Canada) founded in 2017 by Steven ten Holder, Laura Vaughan, Patrick Pumputis, and Drew Taylor. It operates as a HealthTech and Subscription Services. Acorn Biolabs has raised $3.33 million across 4 funding rounds from investors including Globalive Capital, TELUS Ventures and Real Ventures. Acorn Biolabs offers products and services including Personalized Regenerative Medicine, Stem Cell Banking, and Cell-Derived Topical Treatments. Acorn Biolabs operates in a competitive market with competitors including StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
- Headquarter Toronto, Canada
- Founders Steven ten Holder, Laura Vaughan, Patrick Pumputis, Drew Taylor
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.33 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Globalive Capital
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acorn Biolabs
Acorn Biolabs offers a comprehensive portfolio of products and services, including Personalized Regenerative Medicine, Stem Cell Banking, and Cell-Derived Topical Treatments.
Stem cells are preserved for personalized regenerative treatments.
Cells are cryogenically frozen to halt aging effects.
Topical treatments are developed using preserved stem cells.
People of Acorn Biolabs
Unlock access to complete
Leadership Team
4 people
Lab Team
2 people
Product Management Team
1 people
Sales and Marketing
1 people
Lead Team
1 people
Unlock access to complete
Funding Insights of Acorn Biolabs
Acorn Biolabs has successfully raised a total of $3.33M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acorn Biolabs
Acorn Biolabs has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Globalive Capital, TELUS Ventures and Real Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in multiple sectors are directed by TELUS Ventures.
|
Locked | Locked | Locked | |
|
Early-stage venture capital is provided to Canadian technology startups by Real Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Acorn Biolabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acorn Biolabs
Investment portfolio details for Acorn Biolabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acorn Biolabs
Detailed financials for Acorn Biolabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acorn Biolabs Comparisons
Peer comparison for Acorn Biolabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acorn Biolabs
Acorn Biolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemCyte, China Cord Blood, Generate, LaCell and Forever Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| Locked | Locked | Locked |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| Locked | Locked | Locked |
Provider of services for the storage of stem cells
|
|
| Locked | Locked | Locked |
Stem Cell Production
|
|
| Locked | Locked | Locked |
Stem cells are stored and preserved for future therapeutic applications.
|
|
| Locked | Locked | Locked |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Detailed competitors of Acorn Biolabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acorn Biolabs
Complete news archive for Acorn Biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acorn Biolabs
Acorn Biolabs was founded in 2017.
Acorn Biolabs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Drew Taylor is the current CEO of Acorn Biolabs. They have also founded this company.
Acorn Biolabs is a funded company, having raised a total of $3.33M across 4 funding rounds to date.
Acorn Biolabs is focused on personalized regenerative medicine by preserving stem cells for future treatments. Services are offered in the healthcare sector, targeting skin rejuvenation, hair regrowth, injury recovery, and disease treatment. Innovative solutions are developed using cryopreservation of clients own cells to halt aging effects. The potential of regenerative therapies is explored to address aging, injuries, and chronic conditions through advanced biotechnological approaches.
Acorn Biolabs's top competitors include StemCyte, Forever Labs and China Cord Blood.
Acorn Biolabs offers Personalized Regenerative Medicine, Stem Cell Banking, and Cell-Derived Topical Treatments.
Acorn Biolabs has 6 investors. Key investors include Globalive Capital, TELUS Ventures, Real Ventures, Pool Global Partners, and Epic Capital Management.